CIK: 0001637359 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value ($000): $178,486 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| REPL | Replimune Group | 3,001,319 | $69,691 | 39.0% | $17.40 | +12.3% | Common Stock | 76029N106 |
| NUVB | Nuvation Bio | 15,072,340 | $27,130 | 15.2% | $11.18 | -84.8% | Common Stock Class A | 67080N101 |
| — | Alpine Immune Sciences | 2,029,580 | $20,864 | 11.7% | $9.48 | — | Common Stock | 02083G100 |
| — | Morphic Holding | 309,846 | $17,763 | 10.0% | $19.82 | — | Common Stock | 61775R105 |
| — | Ikena Oncology | 2,249,123 | $14,754 | 8.3% | $28.25 | — | Common Stock | 45175G108 |
| — | Theseus Pharmaceuticals | 711,479 | $6,638 | 3.7% | $12.68 | — | Common Stock | 88369M101 |
| — | Kronos Bio | 3,818,283 | $6,567 | 3.7% | $29.87 | — | Common Stock | 50107A104 |
| SANA | Sana Biotechnology, Inc. | 843,750 | $5,029 | 2.8% | $32.56 | -82.3% | Common Stock | 799566104 |
| — | Spruce Biosciences | 2,161,022 | $4,646 | 2.6% | $24.31 | — | Common Stock | 85209E109 |
| IMUX | Immunic Inc | 1,788,160 | $4,488 | 2.5% | $13.89 | -87.9% | Common Stock | 4525EP101 |
| SYRS | Syros Pharmaceuticals | 251,270 | $792 | 0.4% | $8.12 | -60.4% | Common Stock | 87184Q206 |
| — | Senti Biosciences, Inc. | 195,792 | $123 | 0.1% | $1.97 | — | Common Stock | 81726A100 |